CTRI/2022/02/040590尚未招募4 期
A prospective, multicenter clinical study comparing outcomes of two trifocal toric intraocular lens
Biotech Healthcare Holdings GmbH0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Age of patient >21 years
- •2.Patient diagnosed with cataract
- •3.Patient must have preoperative regular corneal astigmatism between 0.75 to 4.5D as per corneal topography or keratometry
- •4.Calculated IOL Power is within the range of the investigational IOLs
- •5.Patient willing to sing informed consent form
- •6.Clear intraocular media other than cataract
- •7.Female participants of child bearing potential must be willing to ensure that they use effective contraception during the study
排除标准
- •1.Previous intraocular or corneal surgery
- •2.Traumatic Cataract.
- •3.Pregnancy (as stated by patient) or lactation
- •4.Concurrent participation in another drug or device investigation
- •5.Irregular Astigmatism
- •6.Patient receiving chlorquine treatment
- •7.Subjects with any systemic disease that could increase operative risk or confound the outcome
- •8.Active ocular disease in the operative eye other than cataract
- •9.Vulnerable subjects
- •10.Corneal Astigmatism >4.5D
研究者
相似试验
尚未招募
4 期
A prospective, multicenter clinical study comparing outcomes of two trifocal toric intraocular lensh25Senile cataractDRKS00025969Biotech Europe Meditech Inc. Ltd.84
尚未招募
不适用
Multicenter, prospective, randomized study comparing motorized spiral enteroscopy with double balloon enteroscopyK63.8K92.2Other specified diseases of intestineGastrointestinal haemorrhage, unspecifiedDRKS00025890Medizinische Klinik 1 Universitätsmedizin Frankfurt32
招募中
不适用
Comparative study between Diode Laser Surgery and Filtering Surgery as a Primary Surgical Procedure for patients with GlaucomaOpen Angle GlaucomaC11.525.381C11.525.381.407RBR-65rzrvCentro de Referência em Oftalmologia da Universidade Federal de Goiás (CEROF-UFG)
进行中（未招募）
1 期
INTOReTAK : INfliximab and TOcilizumab in Refractory/relapsing TAKayasu arteritisPatients with refractory or relapsing Takayasu Arteritis deseaseEUCTR2018-003753-13-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS50
进行中（未招募）
不适用
A trial in which will be studied if the addition of a medicine that is used for improving platelet counts (eltrombopag) to the regular treatment for aplastic anemia (hATG + CsA) also improves the numbers of other cell lines and therefore the overall bone marrow function.Idiopathic (Severe) Aplastic Anemia, a bone marrow failure syndrome which results in the normal hematopoietic tissue completely missing from the bone marrow, accounting for the subsequent pancytopenia.MedDRA version: 18.0Level: PTClassification code 10002967Term: Aplastic anaemiaSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2014-000363-40-ESEuropean Society for Blood and Marrow Transplantation200